Answers are grounded in this paper and cite their sources.
Computational study shows autonomous pump control stabilizes oxygenation during venovenous extracorporeal membrane oxygenation, highlighting potential for digital-twin platforms.
Venovenous extracorporeal membrane oxygenation (VV-ECMO) is a lifesaving respiratory support therapy growing in clinical volume worldwide. Its physiology is complex, yet management strategies vary widely across centers. Meanwhile, patient-to-patient variability makes standardization difficult. To address these challenges, we previously presented a patient-specific model of VV-ECMO based on the Pulse Physiology Engine (Pulse). However, previous study’s scope was limited to validating steady-state physiology. This work (1) compares transient venous oxygen saturation (SvO 2 ) simulations in Pulse to in vivo pig data, (2) implements pump speed as a model input, and (3) simulates closed-loop pump control using proportional integral (PI) controller. The time constants from SvO 2 simulations show significant, positive correlations with in vivo data (coefficient=0.929, p<0.001). Furthermore, both experimental and simulated time constants show significant, negative correlation with their corresponding blood flow (p<0.05). With pump speed as model input, the model predicts achieved blood flow rate in two different clinical systems with reasonable accuracy. Finally, a well-tuned PI pump controller can reject disturbances induced by the ventilator, while there should be precautions for setpoint SvO 2 change and oxygenator thrombosis. Future work will validate the closed-loop findings in a large animal model to bring Pulse closer towards a digital-twin model of VV-ECMO patients. Clinical Trial Registration not applicable
No takes yet. Share an insight, caveat, or question.
Ukita et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: